RHOA and familial dilated cardiomyopathy: Previous studies have shown that the RhoA/ROCK signaling pathway is activated in the hearts of STZ-induced diabetic rats, and inhibition of this pathway improves the cardiac systolic function of diabetic rats in vitro and in vivo, implying that the RhoA/ROCK pathway plays an important role in DCM (134).